Atheroembolic renal disease with rapid progression and fatal outcome

Atheroembolic renal disease is caused by foreign-body reaction to cholesterol crystals flushed from the atherosclerotic plaques into the small-vessel system of the kidneys. It is an underdiagnosed entity, mostly related to vascular procedures and/or anticoagulation, and prognosis is considered to be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental nephrology 2011-02, Vol.15 (1), p.159-163
Hauptverfasser: Faria, Bernardo, Vidinha, Joana, Pêgo, Cátia, Garrido, Jesus, Lemos, Sérgio, Lima, Carla, Sorbo, Giovanni, Gomes, Edgar Lorga, Carvalho, Teresa, Loureiro, Paulo, Sousa, Tânia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 1
container_start_page 159
container_title Clinical and experimental nephrology
container_volume 15
creator Faria, Bernardo
Vidinha, Joana
Pêgo, Cátia
Garrido, Jesus
Lemos, Sérgio
Lima, Carla
Sorbo, Giovanni
Gomes, Edgar Lorga
Carvalho, Teresa
Loureiro, Paulo
Sousa, Tânia
description Atheroembolic renal disease is caused by foreign-body reaction to cholesterol crystals flushed from the atherosclerotic plaques into the small-vessel system of the kidneys. It is an underdiagnosed entity, mostly related to vascular procedures and/or anticoagulation, and prognosis is considered to be poor. Besides the benefit of aggressive medical prevention of further embolic events, use of steroid therapy has been associated with greater survival. Here we report a case of a patient with a multisystemic presentation of the disease days after performance of percutaneous coronary intervention and anticoagulation initiation due to an episode of myocardial infarction. Renal, cutaneous, ophthalmic, neurological, and possibly muscular and mesenteric involvement was diagnosed. Although medical treatment with corticosteroids and avoidance of further anticoagulation was applied, the patient rapidly progressed to end-stage renal disease requiring hemodialysis and died 6 months after diagnosis. This is a case of catastrophic progression of the disease resistant to therapeutic measures. Focus on diagnosis and more efficient preventive and therapeutic protocols are therefore needed.
doi_str_mv 10.1007/s10157-010-0363-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_852903358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2268706391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-704b75aa3ec2c168823961db7c6247fb29c8ec97c13c63767db040d17a47dda63</originalsourceid><addsrcrecordid>eNp1kE9LwzAYh4MoTqcfwIsUL56ieZs0aY5j_oWBFz2HNMm2jraZSYv47c3oVBA8vYH3-f2SPAhdALkBQsRtBAKFwAQIJpRTTA_QCTAqsBBSHqYzZTkGUcAEnca4IYSUspDHaJID4ZIBnKC7Wb92wbu28k1tsuA63WS2jk5Hl33U_ToLelvbbBv8KrgYa99lurPZUvcJ9ENvfOvO0NFSN9Gd7-cUvT3cv86f8OLl8Xk-W2DDRNljQVglCq2pM7kBXpY5lRxsJQzPmVhWuTSlM1IYoIZTwYWtCCMWhGbCWs3pFF2Pvek174OLvWrraFzT6M75IaqyyCWhtCgTefWH3PghpL_tIJCMcSYTBCNkgo8xuKXahrrV4VMBUTvBahSskmC1E6xoylzui4eqdfYn8W00AfkIxLTqVi783vx_6xdkQ4TQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>851944649</pqid></control><display><type>article</type><title>Atheroembolic renal disease with rapid progression and fatal outcome</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Faria, Bernardo ; Vidinha, Joana ; Pêgo, Cátia ; Garrido, Jesus ; Lemos, Sérgio ; Lima, Carla ; Sorbo, Giovanni ; Gomes, Edgar Lorga ; Carvalho, Teresa ; Loureiro, Paulo ; Sousa, Tânia</creator><creatorcontrib>Faria, Bernardo ; Vidinha, Joana ; Pêgo, Cátia ; Garrido, Jesus ; Lemos, Sérgio ; Lima, Carla ; Sorbo, Giovanni ; Gomes, Edgar Lorga ; Carvalho, Teresa ; Loureiro, Paulo ; Sousa, Tânia</creatorcontrib><description>Atheroembolic renal disease is caused by foreign-body reaction to cholesterol crystals flushed from the atherosclerotic plaques into the small-vessel system of the kidneys. It is an underdiagnosed entity, mostly related to vascular procedures and/or anticoagulation, and prognosis is considered to be poor. Besides the benefit of aggressive medical prevention of further embolic events, use of steroid therapy has been associated with greater survival. Here we report a case of a patient with a multisystemic presentation of the disease days after performance of percutaneous coronary intervention and anticoagulation initiation due to an episode of myocardial infarction. Renal, cutaneous, ophthalmic, neurological, and possibly muscular and mesenteric involvement was diagnosed. Although medical treatment with corticosteroids and avoidance of further anticoagulation was applied, the patient rapidly progressed to end-stage renal disease requiring hemodialysis and died 6 months after diagnosis. This is a case of catastrophic progression of the disease resistant to therapeutic measures. Focus on diagnosis and more efficient preventive and therapeutic protocols are therefore needed.</description><identifier>ISSN: 1342-1751</identifier><identifier>EISSN: 1437-7799</identifier><identifier>DOI: 10.1007/s10157-010-0363-3</identifier><identifier>PMID: 21069411</identifier><identifier>CODEN: CENPFV</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Aged ; Case Report ; Embolism, Cholesterol - complications ; Embolism, Cholesterol - immunology ; Embolism, Cholesterol - mortality ; Embolism, Cholesterol - pathology ; Fatal Outcome ; Foreign-Body Reaction - complications ; Humans ; Kidney Diseases - etiology ; Kidney Diseases - mortality ; Kidney Diseases - pathology ; Kidney Diseases - physiopathology ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - physiopathology ; Male ; Medicine ; Medicine &amp; Public Health ; Nephrology ; Renal Dialysis ; Urology</subject><ispartof>Clinical and experimental nephrology, 2011-02, Vol.15 (1), p.159-163</ispartof><rights>Japanese Society of Nephrology 2010</rights><rights>Japanese Society of Nephrology 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-704b75aa3ec2c168823961db7c6247fb29c8ec97c13c63767db040d17a47dda63</citedby><cites>FETCH-LOGICAL-c478t-704b75aa3ec2c168823961db7c6247fb29c8ec97c13c63767db040d17a47dda63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10157-010-0363-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10157-010-0363-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21069411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Faria, Bernardo</creatorcontrib><creatorcontrib>Vidinha, Joana</creatorcontrib><creatorcontrib>Pêgo, Cátia</creatorcontrib><creatorcontrib>Garrido, Jesus</creatorcontrib><creatorcontrib>Lemos, Sérgio</creatorcontrib><creatorcontrib>Lima, Carla</creatorcontrib><creatorcontrib>Sorbo, Giovanni</creatorcontrib><creatorcontrib>Gomes, Edgar Lorga</creatorcontrib><creatorcontrib>Carvalho, Teresa</creatorcontrib><creatorcontrib>Loureiro, Paulo</creatorcontrib><creatorcontrib>Sousa, Tânia</creatorcontrib><title>Atheroembolic renal disease with rapid progression and fatal outcome</title><title>Clinical and experimental nephrology</title><addtitle>Clin Exp Nephrol</addtitle><addtitle>Clin Exp Nephrol</addtitle><description>Atheroembolic renal disease is caused by foreign-body reaction to cholesterol crystals flushed from the atherosclerotic plaques into the small-vessel system of the kidneys. It is an underdiagnosed entity, mostly related to vascular procedures and/or anticoagulation, and prognosis is considered to be poor. Besides the benefit of aggressive medical prevention of further embolic events, use of steroid therapy has been associated with greater survival. Here we report a case of a patient with a multisystemic presentation of the disease days after performance of percutaneous coronary intervention and anticoagulation initiation due to an episode of myocardial infarction. Renal, cutaneous, ophthalmic, neurological, and possibly muscular and mesenteric involvement was diagnosed. Although medical treatment with corticosteroids and avoidance of further anticoagulation was applied, the patient rapidly progressed to end-stage renal disease requiring hemodialysis and died 6 months after diagnosis. This is a case of catastrophic progression of the disease resistant to therapeutic measures. Focus on diagnosis and more efficient preventive and therapeutic protocols are therefore needed.</description><subject>Aged</subject><subject>Case Report</subject><subject>Embolism, Cholesterol - complications</subject><subject>Embolism, Cholesterol - immunology</subject><subject>Embolism, Cholesterol - mortality</subject><subject>Embolism, Cholesterol - pathology</subject><subject>Fatal Outcome</subject><subject>Foreign-Body Reaction - complications</subject><subject>Humans</subject><subject>Kidney Diseases - etiology</subject><subject>Kidney Diseases - mortality</subject><subject>Kidney Diseases - pathology</subject><subject>Kidney Diseases - physiopathology</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nephrology</subject><subject>Renal Dialysis</subject><subject>Urology</subject><issn>1342-1751</issn><issn>1437-7799</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE9LwzAYh4MoTqcfwIsUL56ieZs0aY5j_oWBFz2HNMm2jraZSYv47c3oVBA8vYH3-f2SPAhdALkBQsRtBAKFwAQIJpRTTA_QCTAqsBBSHqYzZTkGUcAEnca4IYSUspDHaJID4ZIBnKC7Wb92wbu28k1tsuA63WS2jk5Hl33U_ToLelvbbBv8KrgYa99lurPZUvcJ9ENvfOvO0NFSN9Gd7-cUvT3cv86f8OLl8Xk-W2DDRNljQVglCq2pM7kBXpY5lRxsJQzPmVhWuTSlM1IYoIZTwYWtCCMWhGbCWs3pFF2Pvek174OLvWrraFzT6M75IaqyyCWhtCgTefWH3PghpL_tIJCMcSYTBCNkgo8xuKXahrrV4VMBUTvBahSskmC1E6xoylzui4eqdfYn8W00AfkIxLTqVi783vx_6xdkQ4TQ</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Faria, Bernardo</creator><creator>Vidinha, Joana</creator><creator>Pêgo, Cátia</creator><creator>Garrido, Jesus</creator><creator>Lemos, Sérgio</creator><creator>Lima, Carla</creator><creator>Sorbo, Giovanni</creator><creator>Gomes, Edgar Lorga</creator><creator>Carvalho, Teresa</creator><creator>Loureiro, Paulo</creator><creator>Sousa, Tânia</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110201</creationdate><title>Atheroembolic renal disease with rapid progression and fatal outcome</title><author>Faria, Bernardo ; Vidinha, Joana ; Pêgo, Cátia ; Garrido, Jesus ; Lemos, Sérgio ; Lima, Carla ; Sorbo, Giovanni ; Gomes, Edgar Lorga ; Carvalho, Teresa ; Loureiro, Paulo ; Sousa, Tânia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-704b75aa3ec2c168823961db7c6247fb29c8ec97c13c63767db040d17a47dda63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Case Report</topic><topic>Embolism, Cholesterol - complications</topic><topic>Embolism, Cholesterol - immunology</topic><topic>Embolism, Cholesterol - mortality</topic><topic>Embolism, Cholesterol - pathology</topic><topic>Fatal Outcome</topic><topic>Foreign-Body Reaction - complications</topic><topic>Humans</topic><topic>Kidney Diseases - etiology</topic><topic>Kidney Diseases - mortality</topic><topic>Kidney Diseases - pathology</topic><topic>Kidney Diseases - physiopathology</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nephrology</topic><topic>Renal Dialysis</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Faria, Bernardo</creatorcontrib><creatorcontrib>Vidinha, Joana</creatorcontrib><creatorcontrib>Pêgo, Cátia</creatorcontrib><creatorcontrib>Garrido, Jesus</creatorcontrib><creatorcontrib>Lemos, Sérgio</creatorcontrib><creatorcontrib>Lima, Carla</creatorcontrib><creatorcontrib>Sorbo, Giovanni</creatorcontrib><creatorcontrib>Gomes, Edgar Lorga</creatorcontrib><creatorcontrib>Carvalho, Teresa</creatorcontrib><creatorcontrib>Loureiro, Paulo</creatorcontrib><creatorcontrib>Sousa, Tânia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faria, Bernardo</au><au>Vidinha, Joana</au><au>Pêgo, Cátia</au><au>Garrido, Jesus</au><au>Lemos, Sérgio</au><au>Lima, Carla</au><au>Sorbo, Giovanni</au><au>Gomes, Edgar Lorga</au><au>Carvalho, Teresa</au><au>Loureiro, Paulo</au><au>Sousa, Tânia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atheroembolic renal disease with rapid progression and fatal outcome</atitle><jtitle>Clinical and experimental nephrology</jtitle><stitle>Clin Exp Nephrol</stitle><addtitle>Clin Exp Nephrol</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>15</volume><issue>1</issue><spage>159</spage><epage>163</epage><pages>159-163</pages><issn>1342-1751</issn><eissn>1437-7799</eissn><coden>CENPFV</coden><abstract>Atheroembolic renal disease is caused by foreign-body reaction to cholesterol crystals flushed from the atherosclerotic plaques into the small-vessel system of the kidneys. It is an underdiagnosed entity, mostly related to vascular procedures and/or anticoagulation, and prognosis is considered to be poor. Besides the benefit of aggressive medical prevention of further embolic events, use of steroid therapy has been associated with greater survival. Here we report a case of a patient with a multisystemic presentation of the disease days after performance of percutaneous coronary intervention and anticoagulation initiation due to an episode of myocardial infarction. Renal, cutaneous, ophthalmic, neurological, and possibly muscular and mesenteric involvement was diagnosed. Although medical treatment with corticosteroids and avoidance of further anticoagulation was applied, the patient rapidly progressed to end-stage renal disease requiring hemodialysis and died 6 months after diagnosis. This is a case of catastrophic progression of the disease resistant to therapeutic measures. Focus on diagnosis and more efficient preventive and therapeutic protocols are therefore needed.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>21069411</pmid><doi>10.1007/s10157-010-0363-3</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1342-1751
ispartof Clinical and experimental nephrology, 2011-02, Vol.15 (1), p.159-163
issn 1342-1751
1437-7799
language eng
recordid cdi_proquest_miscellaneous_852903358
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Aged
Case Report
Embolism, Cholesterol - complications
Embolism, Cholesterol - immunology
Embolism, Cholesterol - mortality
Embolism, Cholesterol - pathology
Fatal Outcome
Foreign-Body Reaction - complications
Humans
Kidney Diseases - etiology
Kidney Diseases - mortality
Kidney Diseases - pathology
Kidney Diseases - physiopathology
Kidney Failure, Chronic - mortality
Kidney Failure, Chronic - physiopathology
Male
Medicine
Medicine & Public Health
Nephrology
Renal Dialysis
Urology
title Atheroembolic renal disease with rapid progression and fatal outcome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atheroembolic%20renal%20disease%20with%20rapid%20progression%20and%20fatal%20outcome&rft.jtitle=Clinical%20and%20experimental%20nephrology&rft.au=Faria,%20Bernardo&rft.date=2011-02-01&rft.volume=15&rft.issue=1&rft.spage=159&rft.epage=163&rft.pages=159-163&rft.issn=1342-1751&rft.eissn=1437-7799&rft.coden=CENPFV&rft_id=info:doi/10.1007/s10157-010-0363-3&rft_dat=%3Cproquest_cross%3E2268706391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=851944649&rft_id=info:pmid/21069411&rfr_iscdi=true